Drug
PF614
PF614 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
20%
Ph phase_1
4
80%
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
Phase 2Efficacy & side effects
1(20.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 14 (80.0%)
Phase 21 (20.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
NCT06629402
completedphase_1
Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)
NCT02454712
completedphase_1
A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)
NCT05567354
completedphase_1
A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)
NCT05571345
completedphase_1
Evaluation of Oral PF614 Relative to OxyContin (PF614-102)
NCT05043766
Clinical Trials (5)
Showing 5 of 5 trials
NCT06629402Phase 2
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
NCT02454712Phase 1
Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)
NCT05567354Phase 1
A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)
NCT05571345Phase 1
A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)
NCT05043766Phase 1
Evaluation of Oral PF614 Relative to OxyContin (PF614-102)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5